Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals.
This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses will continue prospering by anchoring themselves in unique market segments.
Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
CNSide Diagnostics, a Plus Therapeutics subsidiary, secured a national agreement with Humana to provide its CNSide CSF Tumor Cell Enumeration test, expanding coverage to 67 million people.
President Donald Trump continues to take aim at major health insurance companies and says he only supports sending money to individuals, not subsidies for insurance companies.
UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.
Although Humana has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Washington D.C. & New York, NY – November 11, 2025 – After weeks of political deadlock and mounting economic uncertainty, a bipartisan resolution to the protracted US government shutdown has sent a wave of relief through financial markets, triggering a broad-based rally across various asset classes, particularly benefiting commodities. The agreement, reached
The stock market experienced a robust start to the week of November 11, 2025, with major U.S. indexes surging on Monday, November 10th. This powerful rally was largely driven by a confluence of positive developments: growing optimism surrounding a potential resolution to the prolonged U.S. government shutdown and
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers and some providers, faced considerable downward pressure. This divergence highlights a sector grappling with a flurry of groundbreaking drug
As of November 10, 2025, a palpable wave of optimism is sweeping through global financial markets, fueled by significant progress in the US Senate towards ending the longest government shutdown in American history, now in its 41st day. The advancement of a bipartisan bill aimed at resolving the impasse has
New York, NY – November 10, 2025 – The Dow Jones Industrial Average surged today, fueled by a wave of investor optimism surrounding a potential breakthrough deal to end the protracted U.S. government shutdown. After weeks of uncertainty and market apprehension, the prospect of a legislative resolution has injected a much-needed
